MX9100465A - Complejos de ciclodextrina para administracion neuroaxial de medicamentos - Google Patents

Complejos de ciclodextrina para administracion neuroaxial de medicamentos

Info

Publication number
MX9100465A
MX9100465A MX9100465A MX9100465A MX9100465A MX 9100465 A MX9100465 A MX 9100465A MX 9100465 A MX9100465 A MX 9100465A MX 9100465 A MX9100465 A MX 9100465A MX 9100465 A MX9100465 A MX 9100465A
Authority
MX
Mexico
Prior art keywords
neuroaxial
medicines
administration
cyclodextrin complexes
cyclodextrin
Prior art date
Application number
MX9100465A
Other languages
English (en)
Inventor
Tony L Yaksh
Harlan F Hill
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX9100465A publication Critical patent/MX9100465A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9100465A 1990-08-01 1991-07-31 Complejos de ciclodextrina para administracion neuroaxial de medicamentos MX9100465A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/560,614 US5180716A (en) 1990-08-01 1990-08-01 Cyclodextrin complexes for neuraxial administration of drugs

Publications (1)

Publication Number Publication Date
MX9100465A true MX9100465A (es) 1992-04-01

Family

ID=24238560

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100465A MX9100465A (es) 1990-08-01 1991-07-31 Complejos de ciclodextrina para administracion neuroaxial de medicamentos

Country Status (7)

Country Link
US (1) US5180716A (es)
AU (1) AU8404991A (es)
IE (1) IE912715A1 (es)
IL (1) IL99022A0 (es)
MX (1) MX9100465A (es)
WO (1) WO1992002256A1 (es)
ZA (1) ZA916009B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0630261A4 (en) * 1992-03-11 1996-11-06 Australian Commercial Research NEW CYCLODESTRINS AND NEW FORMULA DRUGS.
JP3545403B2 (ja) * 1993-04-22 2004-07-21 スカイファルマ インコーポレイテッド 医薬化合物を被包しているシクロデキストリンリポソーム及びその使用法
DK94093D0 (da) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg Lokalanaestetisk praeparat
DK93993D0 (da) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg Anvendelse af 2-hydroxypropyl-beta-cyclodextrin til fremstilling af et systemisk analgetisk opioidpraeparat
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
AU4975996A (en) * 1995-02-10 1996-08-27 Matthew A Bergan Method and device for administering analgesics
FR2741079B1 (fr) * 1995-11-13 1997-12-26 Oreal Nouveaux composes, derives de cyclodextrine et leur utilisation, notamment en cosmetique
WO1997049402A1 (en) * 1996-06-27 1997-12-31 Janssen Pharmaceutica N.V. Sustained release sufentanil compositions
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
US6391862B1 (en) * 1997-10-14 2002-05-21 The Texas A&M University System Chiral resolving agents for enantioseparations
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
US7906514B1 (en) * 1998-12-07 2011-03-15 Trustees Of Dartmouth College Animal model and compounds identified via this model for treatment of chronic pain
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
CN1241576C (zh) * 1999-08-13 2006-02-15 阿克佐诺贝尔公司 化学螯合剂用于制备逆转临床使用的神经肌肉传导阻滞剂药物诱发的神经肌肉传导阻滞的药物的用途
US6544579B1 (en) 1999-10-18 2003-04-08 Land O'lakes, Inc. Trans-isomer-free fat blend and a process for forming the trans-isomer-free fat blend
TWI242015B (en) * 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
WO2002045713A2 (en) * 2000-12-04 2002-06-13 Sepracor, Inc. Orally-bioavailable formulations of fentanyl and congeners thereof
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
FI20020333A0 (fi) * 2002-02-20 2002-02-20 Tomi Jaervinen Metyloidun syklodekstriinin uudet kompleksit
FI113340B (fi) * 2002-02-20 2004-04-15 Tomi Jaervinen Uudet luonnon syklodekstriinin kompleksit
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN106389307A (zh) 2009-05-29 2017-02-15 锡德克斯药物公司 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法
US8697667B2 (en) * 2010-10-18 2014-04-15 Rutgers, The State University Of New Jersey Cyclodextrin-modified polyamines for delivery of therapeutic molecules
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
USD802755S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
AU2018263924B2 (en) * 2017-05-03 2024-07-04 Cydex Pharmaceuticals, Inc. Composition containing cyclodextrin and busulfan

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108027A (en) * 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) * 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery

Also Published As

Publication number Publication date
IE912715A1 (en) 1992-02-12
AU8404991A (en) 1992-03-02
ZA916009B (en) 1992-07-29
US5180716A (en) 1993-01-19
WO1992002256A1 (en) 1992-02-20
IL99022A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
MX9100465A (es) Complejos de ciclodextrina para administracion neuroaxial de medicamentos
MX9101175A (es) Composicion farmaceutica para administracion nasal
DK360988D0 (da) Farmaceutiske cyclodextrinholdige praeparater
NO920067D0 (no) Foradditiv for droevtyggere
ITMI913324A0 (it) Agenti farmaceutici
DK0515312T3 (da) Farmaceutisk præparat
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922252A (fi) Farmaceutisk sammansaettning
MX165003B (es) Procedimiento para la preparacion de conjugados de medicamentos citotoxicos
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI930882A0 (fi) Farmaceutiska foereningar
MX164971B (es) Procedimiento para la preparacion de conjugados de medicamentos citoxicos
DE69133088D1 (de) Pharmazeutisch wirksame benzochinazolin verbindungen
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A (fi) Farmaceutiska foereningar
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
UA26064A1 (uk) Фармацевтичhа композиція
DK86492D0 (da) Laegemiddel
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
DK0511991T3 (da) Farmaceutisk formulering
NO306381B1 (no) Farmasöytisk ampulle
DK137591D0 (da) Fast farmaceutisk praeparat
DE69132145D1 (de) Peritoneal wirksame medikamente
MX9102627A (es) Composicion farmaceutica de dobutamina para administracion transdermica.
DK7190D0 (da) Laegemiddel